Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-013445
Filing Date
2017-08-01
Accepted
2017-08-01 10:02:49
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20170630_10q.htm 10-Q 1063526
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15296
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 15270
4 EXHIBIT 32 ex32.htm EX-32 6387
  Complete submission text file 0001437749-17-013445.txt   3957395

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxfd-20170630.xml EX-101.INS 728281
6 XBRL TAXONOMY EXTENSION SCHEMA oxfd-20170630.xsd EX-101.SCH 36953
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxfd-20170630_cal.xml EX-101.CAL 41840
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxfd-20170630_def.xml EX-101.DEF 258159
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxfd-20170630_lab.xml EX-101.LAB 221385
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxfd-20170630_pre.xml EX-101.PRE 274561
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 17995347
SIC: 2835 In Vitro & In Vivo Diagnostic Substances